US Stock MarketDetailed Quotes

ARDS Aridis Pharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Feb 11 09:49 ET
4.46KMarket Cap0.00P/E (TTM)

Aridis Pharmaceuticals Key Stats

Aridis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3417.000K / 1.500M--
--2022/Q41.213M / 308.330K--
--2022/Q3399.000K / 7.467M--
--2022/Q2292.000K / 10.463M--
--2022/Q11.187M / 1.000M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3417.000K / 1.500M--
--2022/Q41.213M / 308.330K--
--2022/Q3399.000K / 7.467M--
--2022/Q2292.000K / 10.463M--
--2022/Q11.187M / 1.000M--

Unlock Free Earnings Estimates

Aridis Pharmaceuticals Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.